GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: PKI
Neutral $49

Perkinelmer, Inc. (NYSE: PKI) downgraded to Neutral with price target $49 by ISI Group

Wednesday,  Apr 9, 2014  12:00 AM ET by Kristen Bailey

ISI Group downgraded Perkinelmer, Inc. (NYSE: PKI) to Neutral with price
target $49. ISI Group rated Perkinelmer, Inc. (NYSE: PKI) to Buy with price target $36 on 04/26/2013, when the price was $29.90.

Perkinelmer, Inc. is a provider of technology, services and solutions to the diagnostics, academic research, environmental monitoring and safety and security markets. During the fiscal year ended December 28, 2008 (fiscal 2008), the Company operated in two segments: Life and Analytical Sciences, and Optoelectronics. Subsequent to the fiscal 2008, the Company operates in two segments: Human Health and Environmental Health. In January 2009, it acquired Opto Technology Inc. (Opto Technology). In December 2008, the Company acquired Arnel, Inc. (Arnel). In December 2008, it shut down the Cellular Screening Fluorescence and Luminescence workstations business, Analytical Proteomics Instruments business, and Proteomics and Genomics Instruments business. In May 2009, the Company acquired Analytica of Branford, Inc. In September 2009, the Company acquired the genetic screening business of Surendra Genetic Labs, Pvt Ltd. and SYM-BIO Lifescience.

ISI Group, founded in 1991, strives to create and deliver the most useful investment research for our clients’ money management performance. Today we are a full service broker-dealer offering macro research, fundamental research, trading, and sales. We have 195 employees around the world with our headquarters in New York and offices located in Boston, Fairhope, London, Los Angeles, San Francisco, Shanghai and Washington DC. Our clients are institutional investors around the world.



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy